Statistics from Altmetric.com
Randomised controlled trial.
Follow up period:
University Medical Centre Utrecht, the Netherlands; October 1998 to June 2002.
Ninety six adult outpatients with DSM-IV obsessive-compulsive disorder (OCD) who had responded to three months of medication (⩾25% reduction in score on Yale-Brown Obsessive Compulsive Scale (Y-BOCS)) with venlafaxine (300 mg/day) or paroxetine (60 mg/day). Exclusion criteria: comorbid Axis I disorder during past six months; Hamilton Rating Scale for Depression score >16; and cognitive and/or …
For correspondence: Nienke H Tenneij, PhD, Vrije Universiteit Amsterdam, Developmental Psychology, Van der Boechorststraat, 11081 BT Amsterdam, the Netherlands;
Sources of funding: GlaxoSmithKline and Wyeth Pharmaceuticals, the Netherlands.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.